Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report-Reference-Cited by-同舟云学术

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report

Published:2003-08 Issue:8 Volume:48 Page:2122-2127
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Gómez-Reino Juan J.,Carmona Loreto,Valverde Vicente Rodríguez,Mola Emilio Martín,Montero Maria Dolores

Funder

Agencia Española del Medicamento (Ministerio de Sanidad y Consumo)

Spanish Society of Rheumatology

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference15 articles.

1. Infliximab and methotrexate in the treatment of rheumatoid arthritis;Lipsky;N Engl J Med,2000

2. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial;Maini;Lancet,1999

3. Anti-tumor necrosis factor therapies;Taylor;Curr Opin Rheumatol,2001

4. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent;Keane;N Engl J Med,2001

Cited by 860 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review;Journal of Clinical Epidemiology;2024-09

2. Applications of Biological Therapy for Latent Infections: Benefits and Risks;International Journal of Molecular Sciences;2024-08-24

3. (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review;Clinical Microbiology and Infection;2024-08

4. Identification of immune-associated genes involved in latent Mycobacterium marinum infection;Microbes and Infection;2024-08

5. The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy;Journal of Infection and Public Health;2024-06